Mucosal Microbiome in Patients with Early Bowel Polyps: Inferences from Short-Read and Long-Read 16S rRNA Sequencing
Cancers · 19.10.2023 · 15 (20) · 5045
DOI: 10.3390/cancers15205045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 19.10.2023. Verfasst von Zoe Welham und 3 weiteren Autor:innen. Beteiligte Einrichtung: Bowel Cancer and Biomarker Laboratory, School of Medical Sciences, The University of Sydney, Sydney 2065, Australia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Council NSW, Tour de Cure Foundation, Tour de Cure.
Abstract (Originalsprache)
Numerous studies have correlated dysbiosis in stool microbiota with colorectal cancer (CRC); however, fewer studies have investigated the mucosal microbiome in pre-cancerous bowel polyps. The short-read sequencing of variable regions in the 16S rRNA gene has commonly been used to infer bacterial taxonomy, and this has led, in part, to inconsistent findings between studies. Here, we examined mucosal microbiota from patients who presented with one or more polyps, compared to patients with no polyps, at the time of colonoscopy. We evaluated the results obtained using both short-read and PacBio long-read 16S rRNA sequencing. Neither sequencing technology identified significant differences in microbial diversity measures between patients with or without bowel polyps. Differential abundance measures showed that amplicon sequence variants (ASVs) associated with Ruminococcus gnavus and Escherichia coli were elevated in mucosa from polyp patients, while ASVs associated with Parabacteroides merdae, Veillonella nakazawae, and Sutterella wadsworthensis were relatively decreased. Only R. gnavus was consistently identified using both sequencing technologies as being altered between patients with polyps compared to patients without polyps, suggesting differences in technologies and bioinformatics processing impact study findings. Several of the differentially abundant bacteria identified using either sequencing technology are associated with inflammatory bowel diseases despite these patients being excluded from the current study, which suggests that early bowel neoplasia may be associated with a local inflammatory niche.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bowel Cancer and Biomarker Laboratory, School of Medical Sciences, The University of Sydney, Sydney 2065, Australia.
- Colorectal Surgical Unit, Royal North Shore Hospital, Sydney 2065, Australia.
- Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney 2050, Australia.
ORCID-Profile: Jun Li, Alexander F Engel, Mark P Molloy
Förderung
- Cancer Council NSW
- Tour de Cure Foundation
- Tour de Cure
- Bowel Cancer Research Foundation Australia
- Penn Foundation
Zitieren
APA
Welham, Z., Li, J., Engel, A. F., & Molloy, M. P. (2023). Mucosal Microbiome in Patients with Early Bowel Polyps: Inferences from Short-Read and Long-Read 16S rRNA Sequencing. Cancers, 15(20), 5045. https://doi.org/10.3390/cancers15205045
Vancouver
Welham Z, Li J, Engel AF, Molloy MP. Mucosal Microbiome in Patients with Early Bowel Polyps: Inferences from Short-Read and Long-Read 16S rRNA Sequencing. Cancers. 2023;15(20):5045. doi:10.3390/cancers15205045
BibTeX
@article{Welham2023,
author = {Welham, Zoe and Li, Jun and Engel, Alexander F and Molloy, Mark P},
title = {Mucosal Microbiome in Patients with Early Bowel Polyps: Inferences from Short-Read and Long-Read 16S rRNA Sequencing},
journal = {Cancers},
year = {2023},
volume = {15},
number = {20},
pages = {5045},
doi = {10.3390/cancers15205045}
}
EUVIMED